Further investigations of the expression of SV40-induced surface antigens subsequent to enzymatic treatment of transformed cells.
D000818:Animals; D000956:Antigens, Viral; D001666:Binding Sites, Antibody; D002118:Calcium / Q000494:pharmacology; D002250:Carbon Radioisotopes; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D002614:Chelating Agents / Q000494:pharmacology; D002794:Choline / Q000378:metabolism; D002855:Chromatography, Thin Layer; D003016:Clostridium perfringens / Q000201:enzymology; D004075:Diglycerides / Q000096:biosynthesis; D004492:Edetic Acid / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D005990:Glycerol / Q000378:metabolism; D007553:Isotope Labeling; D007668:Kidney; D008856:Microscopy, Fluorescence; D010713:Phosphatidylcholines / Q000096:biosynthesis; D010740:Phospholipases; D011817:Rabbits; D013539:Simian virus 40 / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D014316:Tritium
D000956:Antigens, Viral; D002250:Carbon Radioisotopes; D002614:Chelating Agents; D004075:Diglycerides; D010713:Phosphatidylcholines; D014316:Tritium; D004492:Edetic Acid; D010740:Phospholipases; D002794:Choline; D005990:Glycerol; D002118:Calcium